Sigachi Industries – A Rising Star in Pharma Excipients
Sigachi Industries is a leading manufacturer of microcrystalline cellulose (MCC), a critical excipient used in the pharmaceutical and nutraceutical industry. Founded in 1989, the company has evolved into a global supplier with three manufacturing units in India and a strong presence across international markets. Sigachi’s core product, MCC, is widely used in tablet formulation, and the company also produces varied cellulose-based products for food and cosmetic industries.
Sigachi Industries gained massive attention during its IPO in November 2021, which was oversubscribed more than 100 times, and delivered outstanding listing gains of over 250%. Since then, its share price has remained a topic of interest for retail and institutional investors alike. The company’s consistent revenue growth, operational efficiency, and ongoing expansion into value-added products make it a promising mid-cap investment. Analysts believe that with the increasing demand for pharmaceutical excipients and Sigachi’s innovation-led approach, it has significant long-term potential in the specialty chemicals sector.